◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SDGR

Schrodinger Inc (SDGR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · HEALTH INFORMATION SERVICES · DATA UPDATED 2026-09-15

Schrodinger Inc (SDGR) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in New York, United States with about 850 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, SDGR reported $256M in revenue and ($103M) in net income.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.

Interactive charts & full statements → Open the SDGR valuation workbench →

SDGR Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Total Revenue	$259M	$256M	$208M	$217M	$181M	$138M	$108M	$86M	$67M	$56M
Gross Profit	$147M	$143M	$132M	$141M	$101M	$66M	$63M	$49M	$43M	$40M
Gross Margin %	56.9%	55.7%	63.6%	64.9%	55.8%	47.6%	58.7%	57.4%	64.4%	71.5%
Operating Income (EBIT)	($153M)	($167M)	($209M)	($177M)	($147M)	($111M)	($61M)	($39M)	($28M)	($19M)
Operating Margin %	-59.2%	-65.2%	-100.8%	-81.9%	-81.1%	-80.8%	-56.4%	-45.3%	-42.0%	-34.2%
Net Income	($54M)	($103M)	($187M)	$41M	($149M)	($100M)	($24M)	($25M)	($28M)	($17M)
Net Margin %	-21.0%	-40.4%	-90.2%	18.8%	-82.4%	-72.8%	-22.6%	-28.7%	-42.7%	-31.2%
EBITDA	($46M)	($96M)	($180M)	$48M	($145M)	($98M)	($57M)	($35M)	($25M)	($17M)
Earnings Per Share (EPS)	$-0.74	$-1.41	$-2.57	$0.54	$-2.10	$-1.42	$-0.41	$-0.39	$-0.59	$-3.07
Shares Outstanding (M)	76M	73M	73M	75M	71M	71M	60M	63M	48M	6M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SDGR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$59M	$59M	$87M	$54M	$55M	$60M	$88M	$35M
Gross Profit	$32M	$30M	$57M	$28M	$26M	$31M	$64M	$18M
Gross Margin %	55.1%	50.4%	65.7%	51.6%	47.8%	52.3%	72.6%	50.2%
Operating Income (EBIT)	($42M)	($49M)	($17M)	($46M)	($53M)	($51M)	($21M)	($68M)
Operating Margin %	-70.5%	-83.3%	-19.7%	-84.6%	-96.6%	-85.5%	-23.4%	-193.9%
Net Income	$6M	($60M)	$33M	($33M)	($43M)	($60M)	($40M)	($38M)
Net Margin %	10.2%	-102.5%	37.3%	-60.4%	-78.8%	-100.4%	-45.5%	-108.1%
EBITDA	$7M	($58M)	$36M	($31M)	($41M)	($58M)	($37M)	($37M)
Earnings Per Share (EPS)	$0.08	$-0.81	$0.44	$-0.45	$-0.59	$-0.82	$-0.55	$-0.52
Shares Outstanding (M)	76M	74M	73M	74M	73M	73M	73M	73M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SDGR Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Cash from Operations (CFO)	($29M)	$14M	($157M)	($137M)	($120M)	($71M)	$17M	($26M)	($24M)	($15M)
Capital Expenditures (CapEx)	$3M	$1M	$7M	$13M	$8M	$7M	$3M	$2M	$5M	$4M
Free Cash Flow (FCF)	($32M)	$12M	($165M)	($150M)	($128M)	($78M)	$14M	($28M)	($29M)	($19M)
FCF Margin %	-12.5%	4.9%	-79.3%	-69.3%	-70.6%	-56.4%	13.2%	-32.6%	-43.5%	-34.1%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SDGR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$64M	($15M)	($16M)	($62M)	($52M)	$144M	($31M)	($33M)
Capital Expenditures (CapEx)	$0M	$3M	$0M	$0M	$0M	$1M	$1M	$1M
Free Cash Flow (FCF)	$63M	($17M)	($16M)	($62M)	($53M)	$143M	($32M)	($35M)
FCF Margin %	107.6%	-29.6%	-18.5%	-114.8%	-95.9%	240.9%	-36.2%	-98.0%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SDGR Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Total Assets	$640M	$726M	$823M	$803M	$689M	$756M	$746M	$155M	$121M	$58M
Cash & Cash Equivalents	$288M	$231M	$147M	$155M	$90M	$120M	$202M	$26M	$78M	$10M
Total Liabilities	$311M	$362M	$402M	$254M	$241M	$199M	$122M	$249M	$192M	$103M
Total Debt (Short + Long-Term)	$16M	$16M	$17M	$17M	$11M	$2M	$5M	$6M	$0M	$0M
Total Shareholders' Equity	$329M	$364M	$421M	$549M	$448M	$557M	$624M	($93M)	($72M)	($45M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SDGR viewer.

Other Companies in HEALTH INFORMATION SERVICES

WAY · Waystar Holding Corp. Common Stock — $5 billion
DOCS · Doximity Inc — $5 billion
HTFL · Heartflow, Inc. Common Stock — $4 billion
PRVA · Privia Health Group Inc — $3 billion
OMCL · Omnicell Inc — $1 billion
CERT · Certara Inc — $1 billion
OMDA · Omada Health, Inc. Common Stock — $1 billion
GDRX · Goodrx Holdings Inc — $1 billion

← SDGH All “S” companies SDGX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.